Despite the strong performance of Microsoft’s medical AI MAI-DxO in testing, which included models from OpenAI, Google, Anthropic, Meta, and xAI, clinical barriers remain.

The company’s MAI-DxO system reached 85% accuracy on challenging NEJM cases, compared to 20% for doctors. The digital health market is growing, and according to Microsoft, its new AI Diagnostic Orchestrator (MAI-DxO) is among the latest in generative,

The company reports in a study published on the preprint site arXiv that its AI-based medical program, the Microsoft AI Diagnostic Orchestrator (MAI-DxO), correctly diagnosed 85% of cases described in the New England Journal of Medicine.